Citation Impact
Citing Papers
Conformal piezoelectric energy harvesting and storage from motions of the heart, lung, and diaphragm
2014 Standout
SNARE Proteins: One to Fuse and Three to Keep the Nascent Fusion Pore Open
2012 StandoutScienceNobel
Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure
2006
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure
2009
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Tetanus toxin channel in phosphatidylserine planar bilayers: conductance states and pH dependence
1990
Distinct sites of action of clostridial neurotoxins revealed by double-poisoning of mouse motor nerve terminals
1987
Activation of Store-Operated Ca2+ Current in Xenopus Oocytes Requires SNAP-25 but Not a Diffusible Messenger
1999 StandoutNobel
Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation
2000
Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more
2006
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2010 Standout
Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity
2006 Nature
Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%
2002
Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy
2004
pH‐dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen
1993
Bcl-xL forms an ion channel in synthetic lipid membranes
1997 Nature
Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
2009
The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications
2015
Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT‐CRT): Design and Clinical Protocol
2005
Experiences of Driving and Driving Restrictions in Recipients With an Implantable Cardioverter Defibrillator-The Patient Perspective
2010
ICD Implantation and Arrhythmia‐Free Survival in Patients with Depressed LV Function Following Surgery for Valvular Heart Disease
2008
Sensitizing Anthrax Lethal Toxin-resistant Macrophages to Lethal Toxin-induced Killing by Tumor Necrosis Factor-α
2003 StandoutNobel
Effect of Anthrax Toxin's Lethal Factor on Ion Channels Formed by the Protective Antigen
1995
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation
2013
-Latrotoxin Stimulates a Novel Pathway of Ca2+-Dependent Synaptic Exocytosis Independent of the Classical Synaptic Fusion Machinery
2009 StandoutNobel
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Protein Translocation through Anthrax Toxin Channels Formed in Planar Lipid Bilayers
2004
Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines
2006
Piezo proteins are pore-forming subunits of mechanically activated channels
2012 StandoutNatureNobel
Right Ventricle Shape and Contraction Patterns and Relation to Magnetic Resonance Imaging Findings
2005
Interaction of tetanus toxin with lipid vesicles. Effects of pH, surface charge, and transmembrane potential on the kinetics of channel formation
1989
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Bacterial protein toxins penetrate cells via a four‐step mechanism
1994
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Pore formation by tetanus toxin, its chain and fragments in neuronal membranes and evaluation of the underlying motifs in the structure of the toxin molecule
1994
Survival in biopsy-proven myocarditis: A long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors
2006
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Frequency and Causes of Implantable Cardioverter-Defibrillator Therapies: Is Device Therapy Proarrhythmic?
2006
Implantable Cardioverter Defibrillators in Patients with Valvular Cardiomyopathy
2012
Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: A meta-analysis of >35,000 patients
2014
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
2014
Mechanism of action of tetanus and botulinum neurotoxins
1994
Tetanus toxin binding to mouse spinal cord cells: an evaluation of the role of gangliosides in toxin internalization
1988
Incidence of and Risk Factors for Sudden Cardiac Death in Children With Dilated Cardiomyopathy
2012
Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25
1993 StandoutNatureNobel
Effect of Cardiac and Noncardiac Conditions on Survival After Defibrillator Implantation
2007
Bacterial protein toxins and cell vesicle trafficking
1996
On the role of polysialoglycosphingolipids as tetanus toxin receptors
1991
Selective Interaction of Complexin with the Neuronal SNARE Complex
2000 StandoutNobel
The N‐terminal half of the heavy chain of botulinum type A neurotoxin forms channels in planar phospholipid bilayers
1987
Identification of an ion channel‐forming motif in the primary structure of tetanus and botulinum neurotoxins
1992
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
The Role of the Wearable Cardioverter Defibrillator in Clinical Practice
2014
Implantable Cardioverter-Defibrillator Shocks
2013
Structure and function of tetanus and botulinum neurotoxins
1995
The Cost Effectiveness of Implantable Cardioverter-Defibrillators
2006
The Entirely Subcutaneous Implantable Cardioverter-Defibrillator
2012
Neurospecific Binding, Internalization, and Retrograde Axonal Transport
1995
Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors
1998 Standout
Direct visualization of botulinum neurotoxin-induced channels in phospholipid vesicles
1993 Nature
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
2008
Usefulness of Sleep-Disordered Breathing to Predict Occurrence of Appropriate and Inappropriate Implantable-Cardioverter Defibrillator Therapy in Patients With Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death
2013
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator
2013
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia
2003
Comparison of Benefit and Mortality of Implantable Cardioverter–Defibrillator Therapy in Patients Aged ≥75 Years Versus Those <75 Years
2011
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Cost-Effectiveness of Implantable Cardioverter–Defibrillators
2005
Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction
2005
Selecting Patients for Discussion of the ICD as Primary Prevention for Sudden Death in Heart Failure
2006
Wearable defibrillator use in heart failure (WIF): results of a prospective registry
2012
Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance Heralds an Adverse Prognosis in Nonischemic Cardiomyopathy
2008
Cellubrevin is a ubiquitous tetanus-toxin substrate homologous to a putative synaptic vesicle fusion protein
1993 StandoutNatureNobel
Frequency of Cardiac Death in Children With Idiopathic Dilated Cardiomyopathy
2009
Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC
1999 StandoutNature
Addendum to “Personal and Public Safety Issues Related to Arrhythmias that May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/Scientific Statement from the American Heart Association and the North American Society of Pacing and Electrophysiology”
2007
Molecular mechanisms of action of bacterial protein toxins
1994
Blockade of a mitochondrial cationic channel by an addressing peptide: An electrophysiological study
1989
Blocking effects of tetanus toxin and its fragment [A-B] on the excitatory and inhibitory synapses of the spinal motoneurone of the cat
1989
Action of diphtheria toxin does not depend on the induction of large, stable pores across biological membranes
1990
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
Sudden Cardiac Death Risk Stratification in Patients With Nonischemic Dilated Cardiomyopathy
2014
Chronic Kidney Disease
2016 Standout
Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction
2004
Use of implantable cardioverter-defibrillators for primary prevention in older patients: A systematic literature review and meta-analysis
2011
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Interaction of tetanus toxin with lipid vesicles at low pH. Protection of specific polypeptides against proteolysis.
1985
Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin.
1996
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Sudden Cardiac Death in Adult Congenital Heart Disease
2012
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
2006
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor
1997 StandoutNobel
Minimal essential domains specifying toxicity of the light chains of tetanus toxin and botulinum neurotoxin type A.
1992
Meta-analysis: Age and Effectiveness of Prophylactic Implantable Cardioverter-Defibrillators
2010
Synaptobrevin/vesicle-associated membrane protein (VAMP) of Aplysia californica: structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F.
1994 StandoutNobel
Characterization of individual polynucleotide molecules using a membrane channel
1996 Standout
A 50‐kDa fragment from the NH2‐terminus of the heavy subunit of Clostridium botulinum type A neurotoxin forms channels in lipid vesicles
1987
Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease
2011
Effect of Amiodarone and Sotalol on Ventricular Defibrillation Threshold
2006
Heterologous combinations of heavy and light chains from botulinum neurotoxin A and tetanus toxin inhibit neurotransmitter release in Aplysia
1991
On the membrane translocation of diphtheria toxin: at low pH the toxin induces ion channels on cells.
1988
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Tetanus toxin is labeled with photoactivatable phospholipids at low pH
1986
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Diphtheria toxin-induced channels in Vero cells selective for monovalent cations.
1988
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Functional assembly of gap junction conductance in lipid bilayers: Demonstration that the major 27 kd protein forms the junctional channel
1987
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients
2005
A model of anthrax toxin lethal factor bound to protective antigen
2005 StandoutNobel
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Acid-induced Dissociation of VacA, the Helicobacter pylori Vacuolating Cytotoxin, Reveals Its Pattern of Assembly
1997
Zanvil Alexander Cohn 1926-1993.
1994 StandoutNobel
Botulinum toxin type A blocks the morphological changes induced by chemical stimulation on the presynaptic membrane of Torpedo synaptosomes.
1989
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Clostridial Neurotoxins: Handling and Action at the Cellular and Molecular Level
1986
Membrane Fusion and Exocytosis
1999 StandoutNobel
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
2009 Standout
Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators
2009
Pathological Ventricular Remodeling
2013
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
2005
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Management of Implantable Cardioverter Defibrillators in End-of-Life Care
2004
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Protein Sorting by Transport Vesicles
1996 StandoutScienceNobel
Binding of the synaptic vesicle v-SNARE, synaptotagmin, to the plasma membrane t-SNARE, SNAP-25, can explain docked vesicles at neurotoxin-treated synapses
1997 StandoutNobel
Effect of pH on the interaction of botulinum neurotoxins A, B and E with liposomes
1989
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Mitochondria and Apoptosis
1998 StandoutScience
Assembly of SNARE Core Complexes Prior to Neurotransmitter Release Sets the Readily Releasable Pool of Synaptic Vesicles
2000 StandoutNobel
Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis.
1986
Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses.
1991 StandoutNobel
Isolated Light Chains of Botulinum Neurotoxins Inhibit Exocytosis
1989
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Characterization of the channel properties of tetanus toxin in planar lipid bilayers
1988
A Study of the Mechanism of Internalisation of Tetanus Toxin by Primary Mouse Spinal Cord Cultures
1987
Anthrax Toxin
2003
Neurotoxins Affecting Neuroexocytosis
2000 Standout
Three-dimensional structure of the anthrax toxin pore inserted into lipid nanodiscs and lipid vesicles
2010
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Anthrax protective antigen forms oligomers during intoxication of mammalian cells.
1994
Late Gadolinium Enhancement on Cardiac Magnetic Resonance Predicts Adverse Cardiovascular Outcomes in Nonischemic Cardiomyopathy
2013
Works of David Hoch being referenced
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
2004
Implantable cardioverter defibrillator: Use in patients with no symptoms and at high risk
1996
Gating of Large Toxin Channels by pH
1985
Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes.
1985
Tachycardias of Right Ventricular Origin
1992
Neuropharmacological characterization of fragment B from tetanus toxin.
1985